Literature DB >> 30264283

Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings from the REMINDER trial.

João Pedro Ferreira1,2, António Barros2, Bertram Pitt3, Gilles Montalescot4, Esteban Lopez de Sa5, Christian W Hamm6, Marcus Flather7, Freek Verheugt8, Harry Shi9, Adelino Leite-Moreira2, John Vincent9, Patrick Rossignol1, Faiez Zannad10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30264283     DOI： 10.1007/s00392-018-1373-5

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  25 in total

1.  Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators.

Authors:  F Zannad; F Alla; B Dousset; A Perez; B Pitt
Journal:  Circulation       Date:  2000-11-28       Impact factor: 29.690

2.  Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance.

Authors:  D Quilliot; F Alla; P Böhme; J-F Bruntz; M Hammadi; B Dousset; O Ziegler; F Zannad
Journal:  Int J Obes (Lond)       Date:  2005-11       Impact factor: 5.095

Review 3.  Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?

Authors:  João Pedro Ferreira; Robert J Mentz; Anne Pizard; Bertram Pitt; Faiez Zannad
Journal:  Eur J Heart Fail       Date:  2017-04-12       Impact factor: 15.534

Review 4.  Myocardial Interstitial Fibrosis in Heart Failure: Biological and Translational Perspectives.

Authors:  Arantxa González; Erik B Schelbert; Javier Díez; Javed Butler
Journal:  J Am Coll Cardiol       Date:  2018-04-17       Impact factor: 24.094

5.  Early Aldosterone Blockade in Acute Myocardial Infarction: The ALBATROSS Randomized Clinical Trial.

Authors:  Farzin Beygui; Guillaume Cayla; Vincent Roule; François Roubille; Nicolas Delarche; Johanne Silvain; Eric Van Belle; Loic Belle; Michel Galinier; Pascal Motreff; Luc Cornillet; Jean-Philippe Collet; Alain Furber; Patrick Goldstein; Patrick Ecollan; Damien Legallois; Alain Lebon; Hélène Rousseau; Jacques Machecourt; Faiez Zannad; Eric Vicaut; Gilles Montalescot
Journal:  J Am Coll Cardiol       Date:  2016-04-26       Impact factor: 24.094

6.  Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin.

Authors:  Begoña López; Arantxa González; Ramón Querejeta; Elena Zubillaga; Mariano Larman; Javier Díez
Journal:  Eur J Heart Fail       Date:  2015-02-11       Impact factor: 15.534

7.  Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study.

Authors:  Hideo Izawa; Toyoaki Murohara; Kohzo Nagata; Satoshi Isobe; Hiroyuki Asano; Tetsuya Amano; Sahoko Ichihara; Tomoko Kato; Satoru Ohshima; Yosuke Murase; Shigeo Iino; Koji Obata; Akiko Noda; Kenji Okumura; Mitsuhiro Yokota
Journal:  Circulation       Date:  2005-11-08       Impact factor: 29.690

Review 8.  Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential.

Authors:  Stephane Heymans; Arantxa González; Anne Pizard; Anna P Papageorgiou; Natalia López-Andrés; Frédéric Jaisser; Thomas Thum; Faiez Zannad; Javier Díez
Journal:  Eur J Heart Fail       Date:  2015-06-30       Impact factor: 15.534

9.  Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis.

Authors:  G Klappacher; P Franzen; D Haab; M Mehrabi; M Binder; K Plesch; R Pacher; M Grimm; I Pribill; H G Eichler
Journal:  Am J Cardiol       Date:  1995-05-01       Impact factor: 2.778

10.  Aldosterone induced galectin-3 secretion in vitro and in vivo: from cells to humans.

Authors:  Yen-Hung Lin; Chia-Hung Chou; Xue-Ming Wu; Yi-Yao Chang; Chi-Sheng Hung; Ying-Hsien Chen; Yu-Lin Tzeng; Vin-Cent Wu; Yi-Lwun Ho; Fon-Jou Hsieh; Kwan-Dun Wu
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.